Eli Lilly Defeats Cymbalta Risk Claims In Bellwether Trial

By Daniel Siegal (August 7, 2015, 6:30 PM EDT) -- A California federal jury Friday rejected claims by a woman who alleged Eli Lilly & Co. concealed the withdrawal risks of its antidepressant Cymbalta, finding the drugmaker did not mislabel the drug and was not liable for the woman's purported withdrawal symptoms....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!